Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioHarvest Sciences (TSE:BHSC)
:BHSC
Holding TSE:BHSC?
Track your performance easily
BHSC Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$6.24 - C$10.50
Previous CloseN/A
Volume0.00
Average Volume (3M)1.16K
Market Cap
C$134.29M
Enterprise ValueC$148.15M
Total Cash (Recent Filing)$1.85K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Apr 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.64
Shares Outstanding17,327,717
10 Day Avg. Volume473
30 Day Avg. Volume1,159
Standard Deviation0.22
R-Squared0.04
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.63
Price to Cash Flow (P/CF)-27.80
P/FCF Ratio44.20
Enterprise Value/Market Cap1.10
Enterprise Value/Revenue6.60
Enterprise Value/Gross Profit26.30
Enterprise Value/Ebitda-15.12
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BioHarvest Sciences News
PremiumCompany Announcements
BioHarvest Sciences Appoints Sharon Malka to Board of Directors
PremiumCompany Announcements
BioHarvest Sciences Appoints Sharon Malka to Board of Directors
PremiumCompany Announcements
BioHarvest and Tate & Lyle Partner for Plant-Based Ingredients
PremiumCompany Announcements
BioHarvest Sciences Surpasses Q3 Revenue ExpectationsPremiumCompany Announcements
BioHarvest Sciences Launches VINIA SuperFood Teas
PremiumCompany Announcements
BioHarvest Sciences Engages Investors at Upcoming ConferenceBHSC FAQ
What was BioHarvest Sciences’s price range in the past 12 months?
BioHarvest Sciences lowest stock price was C$6.24 and its highest was C$10.50 in the past 12 months.
What is BioHarvest Sciences’s market cap?
BioHarvest Sciences’s market cap is C$134.29M.
When is BioHarvest Sciences’s upcoming earnings report date?
BioHarvest Sciences’s upcoming earnings report date is Apr 24, 2025 which is in 83 days.
How were BioHarvest Sciences’s earnings last quarter?
BioHarvest Sciences released its earnings results on Nov 25, 2024. The company reported -C$0.225 earnings per share for the quarter, missing the consensus estimate of -C$0.068 by -C$0.157.
Is BioHarvest Sciences overvalued?
According to Wall Street analysts BioHarvest Sciences’s price is currently Overvalued.
Does BioHarvest Sciences pay dividends?
BioHarvest Sciences does not currently pay dividends.
What is BioHarvest Sciences’s EPS estimate?
BioHarvest Sciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioHarvest Sciences have?
BioHarvest Sciences has 17,327,717 shares outstanding.
What happened to BioHarvest Sciences’s price movement after its last earnings report?
BioHarvest Sciences reported an EPS of -C$0.225 in its last earnings report, missing expectations of -C$0.068. Following the earnings report the stock price went up 1.754%.
Which hedge fund is a major shareholder of BioHarvest Sciences?
Currently, no hedge funds are holding shares in TSE:BHSC
---
BioHarvest Sciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.58%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
143.58%
Trailing 12-Months
Company Description
BioHarvest Sciences
BioHarvest Sciences Inc is the developer and owner of the proprietary and patent protected Biofarming technology. It is the industrial large-scale plant cell growth technology capable of directly and constantly producing the active plant ingredients without the necessity to grow the plant itself. The technology has been already validated by Vinia, the red grapes cells functional food/dietary supplement produced and sold by BioHarvest. By adapting this technology to the Cannabis plant, and building adequate cells production capacity, the company's objective is to be the supplier of Cannabis for both the medicinal and recreational legal use.
---
Technical Analysis
---